Charles River Laboratories International Inc CRL:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EST
239.50UNCH (UNCH)
Volume
3,377
Close
239.50quote price arrow up+2.39 (+1.01%)
Volume
688,289
52 week range
181.36 - 381.12
Loading...
  • Open237.34
  • Day High243.50
  • Day Low237.00
  • Prev Close237.11
  • 52 Week High381.12
  • 52 Week High Date11/29/21
  • 52 Week Low181.36
  • 52 Week Low Date09/27/22

Key Stats

  • Market Cap12.185B
  • Shares Out50.88M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta1.30
  • YTD % Change-36.44

KEY STATS

  • Open237.34
  • Day High243.50
  • Day Low237.00
  • Prev Close237.11
  • 52 Week High381.12
  • 52 Week High Date11/29/21
  • 52 Week Low181.36
  • 52 Week Low Date09/27/22
  • Market Cap12.185B
  • Shares Out50.88M
  • 10 Day Average Volume0.46M
  • Dividend-
  • Dividend Yield-
  • Beta1.30
  • YTD % Change-36.44

RATIOS/PROFITABILITY

  • EPS (TTM)8.49
  • P/E (TTM)28.21
  • Fwd P/E (NTM)22.33
  • EBITDA (TTM)963.904M
  • ROE (TTM)17.27%
  • Revenue (TTM)3.781B
  • Gross Margin (TTM)37.31%
  • Net Margin (TTM)11.72%
  • Debt To Equity (MRQ)111.89%

EVENTS

  • Earnings Date02/14/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Charles River Laboratories International Inc

 

Profile

MORE
Charles River Laboratories International, Inc. is a full service, non-clinical contract research company. The Company provides research models required in research and development of new drugs, devices, and therapies. The Company's segments include Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment includes the research models, research model services, and research and GMP-compliant cells...
James Foster J.D.
Chairman of the Board, President, Chief Executive Officer
Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Flavia Pease
Chief Financial Officer, Corporate Executive Vice President
Joseph LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
William Barbo
Corporate Executive Vice President, Chief Commercial Officer
Address
251 Ballardvale St
Wilmington, MA
01887
United States

Top Peers

SYMBOLLASTCHG%CHG
INCY
Incyte Corp
77.80-0.03-0.04%
NVZMY
Novozymes A/S
57.03-0.40-0.70%
NBIX
Neurocrine Biosciences Inc
121.74+0.08+0.07%
EXAS
Exact Sciences Corp
41.19-0.31-0.75%
SRPT
Sarepta Therapeutics Inc
117.10-1.03-0.87%